))
Special Episode - SMACing Cancer (uOttawa SciComm 2023)
Manage episode 393099166 series 2849626
Contenido proporcionado por BEaTS Research Radio. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente BEaTS Research Radio o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Armita Kalani from the Translational and Molecular Medicine (TMM) program at the University of Ottawa interviews Dr. Shawn Beug on behalf of her team for the TMM4950 Science Communication course. Dr. Shawn Beug is a Scientist at the CHEO Research Institute and an Assistant Professor at the University of Ottawa. Dr. Beug’s research group focuses on understanding the factors involved in apoptosis (programmed cell death) and aims to develop new immune-based therapies for the treatment of cancer. In his quest to defeat cancer, Dr. Beug shares with us his research on a new class of drugs known as 'SMAC mimetics' as well as major findings from his 2017 Nature paper on the use of SMAC mimetics for glioblastoma treatment, and the results from ongoing clinical trials.
To learn more, please visit: https://med.uottawa.ca/bmi/en/people/beug-shawn
Episode credits: Ana Spasojevic (Producer), Armita Kalani (Host), Nicole Chu (Content Writer), Kirsten Chua (Video Editor)
31 episodios
Compartir
